CEL-SCI Corporation CVM

Just how does Geert keep his job? Is there no Board? Firing him would actually call some attention to the stock.

I can’t believe there are people on this board still supporting Geert. I do not understand how he has lasted this long. A drug like MK showing ZERO TOXICITY should have gotten some type of approval based on the improvement in 5 yr survival in the original study. PFE or BMY will buy this company in a fire sale and you will see some type of approval within 90 days after the takeover. I guess some of you traders will be happy with $20/s for a company worth 10x that as a standalone.

I think that we can all agree that you can be a bull on CVM but the “Geert morning” has to stop. He is inept at best and probably corrupt. MK had been around for over 30 years and still no approval or offers. Not even rumors. How a CEO can persist through all of this failure is hard to comprehend. So please, let’s just ban ‘Geert’ from the board. Even if it gets approved tomorrow, it is at least 15 years than a real CEO would have done.

I have been a huge believer in MK but have had little faith in Geert. It looks like bad management will overcome good science and drive CVM shares to ZERO.
The positive news is out there as the stock continues to crater. Would love some positive thoughts here other than cheerleading.

This is a waiting game. Can Merck (or whoever)use their hold over regulatory agencies (esp the horribly corrupt FDA) to bleed CVM of cash and force a sale at a bargain price? This is the endgame here. MK has clear value but the company has no clout and an inept CEO.
Should have been approved long ago.
Investors will do well even at $25 but as a standalone the company is probably worth $150 with approval. As you saw with the COVID vax , the FDA is a wholly owned subsidiary of big pharma

At $2 there must be a lock-up associated with this offering?

One has to think that there has to be reasonable expectation of approval to incur the expense of increasing the manufacturing facility. Somebody somewhere feels there is approval on the horizon. Again, I think this is a stall from the FDA servicing a big pharma company hoping to buy them out in a distress sale.
At this point I would hope we see some kind of takeover bid. Biotech companies being bought with rare disease portfolios. H&N cancer is a huge addressable market

I do not understand the pediatric waiver as MK is for an ADULT disease. Any pediatric applicatons would come after approval as oncologists wish to try on pediatric solid tumors. Again, I do not have faith in Geert. This is all taking WAY too long.

FINALLY, some good news but ?Twitter?
Where are the analysts? Why not put some supporting MD on tv somewhere?
Where is the marketing, Geert? $CVM should be testing prior highs off this news. Nothing is simple with this company.

B.O.D. Needs to dump Geert and key someone who knows how to get a drug across the finish line